Impact of the COVID-19 pandemic on the actions of the Schistosomiasis Control Program in an endemic area in Northeastern Brazil
暂无分享,去创建一个
R. Fujiwara | D. Negrão-Corrêa | C. D. F. de Souza | W. J. Porto | V. Barbosa | Rodrigo Feliciano do Carmo | Wandklebson Silva da Paz | Allan Dantas dos Santos | Flaviana dos Santos Wanderley | L. A. Andrade | Neiliane Medeiros Dantas | Welde Natan Borges | Diego Pereira Gonçalo da Hora | C. E. da Silva | M. Bezerra-Santos
[1] E. D. de Melo,et al. Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk? , 2022, Frontiers in Pharmacology.
[2] Débora Dos Santos Tavares,et al. Educational intervention on scholar’s knowledge regarding schistosomiasis in a riverside community, northeastern Brazil , 2022, Revista de Patologia Tropical / Journal of Tropical Pathology.
[3] A. D. de Jesus,et al. Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study , 2022, The Lancet Regional Health - Americas.
[4] M. V. Peixoto,et al. Spatiotemporal Pattern of COVID-19-Related Mortality during the First Year of the Pandemic in Brazil: A Population-based Study in a Region of High Social Vulnerability. , 2021, The American journal of tropical medicine and hygiene.
[5] A. Azman,et al. Towards global control of parasitic diseases in the Covid-19 era: One Health and the future of multisectoral global health governance , 2021, Advances in Parasitology.
[6] L. Duczmal,et al. How Brazil’s President turned the country into a global epicenter of COVID-19 , 2021, Journal of Public Health Policy.
[7] K. C. G. D. de Araújo,et al. Risk clusters of Schistosoma mansoni infection in an endemic state of Brazil: space-time modelling and association with socio-economic and environmental factors. , 2021, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[8] T. Dzieciątkowski,et al. The New Status of Parasitic Diseases in the COVID-19 Pandemic—Risk Factors or Protective Agents? , 2021, Journal of clinical medicine.
[9] M. Duthie,et al. Population-based, spatiotemporal modeling of social risk factors and mortality from schistosomiasis in Brazil between 1999 and 2018. , 2021, Acta tropica.
[10] Øyunn Holen. Schistosomiasis in the shadow of COVID-19. , 2021, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[11] J. N. Cruz,et al. Retrocesso do Programa de Controle da Esquistossomose no estado de maior prevalência da doença no Brasil , 2020, Revista Pan-Amazônica de Saúde.
[12] T. Hollingsworth,et al. Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies , 2020, medRxiv.
[13] C. King,et al. Human schistosomiasis , 2014, The Lancet.
[14] J. Utzinger,et al. Time to set the agenda for schistosomiasis elimination. , 2013, Acta tropica.
[15] E. Feuer,et al. Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.